Amikacin Sulfate 1 g/4mL (Amikacin Sulfate INJECTION, SOLUTION) 1 g/4mL

Amikacin Sulfate 1 g/4mL is an injectable antibiotic solution used to treat severe bacterial infections. This broad-spectrum medication is available in 10 vials per carton, manufactured by Heritage Pharmaceuticals.

Strength

1 g/4mL

Pack Size

10 VIAL, GLASS in 1 CARTON (23155-786-41) / 4 mL in 1 VIAL, GLASS (23155-786-31)

Manufacturer / TM Owner

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Amikacin Sulfate is primarily used for treating serious bacterial infections, including those resistant to other antibiotics. It is often administered when oral antibiotics are ineffective. This injection is suitable for both intramuscular and intravenous use, targeting a wide range of bacterial strains.

Side Effects

Common effects of Amikacin Sulfate may include temporary discomfort at the injection site, dizziness, or changes in kidney function. Some users may experience hearing changes or balance issues. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Amikacin Sulfate should be handled with care, ensuring proper sterile techniques during administration. Monitor kidney function regularly during treatment. Avoid use in individuals with known allergies to aminoglycoside antibiotics. Store in a cool, dry place away from direct sunlight.

Avoid Interactions

Amikacin Sulfate may interact with other medications, including diuretics, muscle relaxants, and certain anesthetics. Alcohol should be avoided during treatment. Inform your healthcare provider about all medications you are taking to prevent adverse interactions.

Frequently Asked Questions

Amikacin Sulfate is used to treat severe bacterial infections, often when other antibiotics are ineffective.

Amikacin Sulfate can be administered intramuscularly or intravenously, depending on the patient's needs.

Common side effects may include discomfort at the injection site, dizziness, and changes in kidney function.

Amikacin Sulfate may interact with diuretics, muscle relaxants, and anesthetics. Consult a healthcare provider before combining medications.

Store Amikacin Sulfate in a cool, dry place away from direct sunlight and ensure proper sterile techniques during administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.